Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Exact Therapeutics AS
EXTXCurrent price
5 NOK
+0.099 NOK (+2.04%)
Last closed
5 NOK
Company
www.exact-tx.com
ISIN
NO0010852213
Sector
Healthcare
Industry
Biotechnology
Exchange
Oslo Stock Exchange
Capitalization
159 309 082 NOK
Yield for 12 month
-59.68 %
1Y
3Y
5Y
10Y
15Y
EXTX
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company's ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy. EXACT Therapeutics AS has a collaboration with GE Healthcare for the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy; and with Agenus Inc. to develop proprietary immune checkpoint inhibitors in combination with EXACT's Acoustic Cluster Technology, in pancreatic cancer. The company was formerly known as Phoenix Solutions AS. EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway. Address: Østre Aker vei 19, Oslo, Norway, 0581
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures EXTX
1 year
3 years
5 years
10 years
EBITDA
-53 705 278 NOK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-82.91 %
PEG Ratio
–
Return On Equity TTM
-175.64 %
Wall Street Target Price
–
Revenue TTM
–
Book Value
0.54 NOK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
51 645 NOK
Earnings per share
-1.65 NOK
Diluted Eps TTM
-1.65 NOK
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics EXTX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EXTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
250:1
Payout Ratio
–
Last Split Date
27.07.2020
Dividend Date
–
Stock Valuation EXTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
41378.074
Enterprise Value EBITDA
-4.0783
Price Book MRQ
9.199
Financials EXTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXTX
For 52 weeks
4.77 NOK
12.41 NOK
50 Day MA
5.59 NOK
Shares Short Prior Month
–
200 Day MA
7.46 NOK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart